Remdesivir eases covid-19 symptoms in monkeys in 12 hours, small preliminary study shows

  • 📰 Newsweek
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 52%

United States Headlines News

United States Latest News,United States Headlines

There is currently no specific treatment for COVID-19.

shows the global spread of the newas of early April 16. More than 2.1 million people have been afflicted, over 530,000 of whom have recovered and over 140,000 of whom have died.

The study being conducted in animals presented both strengths and weaknesses, said Preston. An animal model shows more than anBut Preston said that effects in animals won't necessarily translate to humans. Preston also argued the study's small sample size was another limitation, so extrapolation the results in a larger sample of subjects"needs to be done with caution."," Preston continued.

treatment should be started, as symptoms do not usually develop until a few days after exposure to the virus. "Both of these options would require rapid identification of cases which would require scaled up community diagnostic screening to be in place."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

This just in. Trump Inc. Is now selling Remdesivir on QVC.

Eases symptoms...not cures the Coronavirus...

100x more expensive than Hydrochloroquine. I wonder why drug companies are pushing it?

so now it can be tested on the trump family ?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 468. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

How the CARES Act Eases Retirement Account Rules During COVID-19The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) aims to help Americans cope with the unprecedented financial fallout from the COVID-19 outbreak. Among its provisions, the CARES Act makes it easier to withdraw funds saved in certain tax-advantaged retirement accounts like 401(k)s and traditional Individual Retirement Accounts (IRAs). These temporary changes eliminate tax penalties […] Stop liking and Start following Wambuu_
Source: Forbes - 🏆 394. / 53 Read more »

A desperate scramble as COVID-19 families vie for access to plasma therapyEven as efforts ramp up to collect blood plasma from the first survivors of coronavirus, chances of procuring treatment appear to depend on geography, social-media savvy, and the willingness of physicians. Listen, anyone that called this virus a hoax shouldn’t get plasma. I make the rules. Luck of the draw doesn't sound like much of a plan. It is the fure for now and especially NYC should treat people with it. Since the enfected numbers are so high, the plasma amount will be high too
Source: NBCNews - 🏆 10. / 86 Read more »

A New Frontier for Self-Love—And Sex Toys—in the Time of COVID-19With an uptick in conversation around female desire and a boom in female-led sex tech companies, one Vogue writer explores self-love in the time of COVID-19. Gorgeous Centerfold 🔥 Can I get permission to use this on my twitter header? Hello? I love this photo, just for a day or so? 🙏🌹🌈 waco_princess21 kimthefaerie
Source: VogueRunway - 🏆 705. / 51 Read more »

Nursing home deaths should be obvious target of COVID-19 responseRachel Maddow reports on how Ireland identified long-term care facilities as being the greatest source of COVID-19 deaths and concentrated resources on that problem, and notes that the United States could consider a similar strategy though likely without help from the derelict federal administration. maddow The underlying issues in an increasingly for-profit industry have to be looked at. LTCconsumer CMAorg Market Watch: “Private-equity takeover of nursing homes has reduced quality of care at critical moment, research suggests”
Source: MSNBC - 🏆 469. / 51 Read more »

Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19“Did remdesivir just ‘solve’ COVID? No,” says Umer Raffat, an analyst at Evercore ISI. Because he's deep state and wants the economy to crash... This drug has been known about for a long time now. It has known side effects as well. That, coupled with some strange call option activity on GILD, seems to suggest that the SEC should be snooping around on this one.
Source: MarketWatch - 🏆 3. / 97 Read more »

Gupta: Federal guidance, Singapore-developed tech needed to fight COVID-19“What we need is creative thinking,' VinGuptaMD says of U.S. issues with testing for COVID-19. 'There are ways to get around these bottlenecks, we just have to have federal guidance.” VinGuptaMD Here's Your Guidance: Get The Fock Around Them And Quit Your Whining. VinGuptaMD Doctor: There are ways to get around these bottlenecks, but I won't say what they are. VinGuptaMD Good luck with getting federal guidance.
Source: MSNBC - 🏆 469. / 51 Read more »